• Dong-A Pharmaceutical and related parties’ stake in Dong-A ST rose to 41.53% from 41.52%, according to the Nov. 6, 2026 disclosure.
• Reported holdings increased by 608 shares to 4,039,817, reflecting four newly appointed executives’ inclusion on Nov. 1.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dong-A ST Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261106000264), on November 06, 2026, and is solely responsible for the information contained therein.